European Union - English - EMA (European Medicines Agency)

ab science s.a. - masitinib mesilate - antineoplastic agents - dogs - treatment of non-resectable dog mast-cell tumours (grade 2 or 3) with confirmed mutated c-kit tyrosine-kinase receptor.